業績集
2023年
The landscape of
MYB/MYBL1- and peri-MYB/MYBL1-associated rearrangements in adenoid cystic
carcinomaKaori
Ueda, Takayuki Murase, Daisuke Kawakita, Toshitaka Nagao, Kimihide Kusafuka,
Masato Nakaguro, Makoto Urano, Hidetaka Yamamoto, Ken-ichi Taguchi, Satoshi
Kano, Yuichiro Tada, Kiyoaki Tsukahara, Kenji Okami, Tetsuro Onitsuka, Yasushi
Fujimoto, Kazuo Sakurai, Nobuhiro Hanai, Toru Nagao, Ryo Kawata, Naohito Hato,
Ken-ichi Nibu, and Hiroshi Inagaki Modern
Pathol in press
Prognostic
Scores for Patients with Salivary Adenoid Cystic Carcinoma without Lymph Node
MetastasisHikari
Shimoda, Masanori Teshima, Takayuki Murase, Toshitaka Nagao, , Kimihide
Kusafuka, Masato Nakaguro, Makoto Urano, Ken-ichi Taguchi, Hidetaka Yamamoto,
Satoshi Kano, Yuichiro Tada, Kiyoaki Tsukahara, Kenji Okami, Tetsuro Onitsuka,
Yasushi Fujimoto, Daisuke Kawakita, Kazuo Sakurai, Nobuhiro Hanai, Toru Nagao,
Ryo Kawata, Naohito Hato, Ken-ichi Nibu, and Hiroshi Inagaki.Oral
Oncol in press
Case report:
Genomic analysis of a therapy-related chronic myelomonocytic leukemia with KMT2A rearrangement that progressed to acute
myeloid leukemia with acute promyelocytic leukemia-like features. Suzuki
T, Yokomori R, Sanda T, Kikuchi T, Marumo Y, Kinoshita S, Narita T, Masaki A,
Ito A, Ri M, Kusumoto S, Komatsu H, Inagaki H, Iida S.Front
Oncol. 2023 Feb 17;13:1116418. doi: 10.3389/fonc.2023.1116418. eCollection
2023.
A descriptive study of Parkinson disease and atypical parkinsonisms in
the Annuals of the Pathological Autopsy Cases in Japan.Sato C, Anan C, Suzuki A, Inagaki A, Tajima T, Hibino H,Inagaki H,Neuropathology. 2022 Nov 6. doi: 10.1111/neup.12876. Online ahead of
print.PMID: 36336970
Aberrant
tryptophan metabolism leads to unfavorable outcomes in lenalidomide-treated
myeloma patients. Asano
A, Ri M, Masaki A, Maeda Y, Tachita T, Hirade K, Marumo Y, Nakashima T,
Hagiwara S, Kinoshita S, Suzuki T, Narita T, Kusumoto S, Komatsu H, Inagaki H,
Iida S.Century
Oncol. 2022 Nov 25. doi: 10.1002/hon.3108. Online ahead of print.PMID:36426594
2022年
CCR7 alterations
associated with inferior outcome of adult T-cell leukemia/lymphoma under
mogamulizumab treatment. Sakamoto Y, Ishida T, Masaki A, Murase T, Ohtsuka E, Takeshita M, Muto R, Iwasaki H, Ito A, Kusumoto S, Nakano N, Tokunaga M, Yonekura K. Tashiro Y, Iida S, Utsunomiya A, Ueda R, Inagaki H.Hematol
Oncol. 2022 Dec;40(5):876-884. doi: 10.1002/hon.3072. Epub 2022 Sep 6.PMID: 36043457 Free PMC
article.
7-Amino-4-methylcoumarin
as a fluorescent substitute for Schiff's reagent: a new method that can be
combined with hemalum and eosin staining on the same tissue section. Takase
H, Murase T, Hachisuka D, Sakamoto Y, Sugiura M, Nakano S, Fujii K, Masaki A,
Inagaki H.Biotech Histochem. 2023 Jan;98(1):54-61. doi:10.1080/10520295.2022.2101144.
Epub 2022 Jul 29.PMID: 35904399
Abnormal
accumulation of OFD1 in endometrial cancer with poor prognosis inhibits
ciliogenesis. Kojima
R, Hassan E, Ozawa F, Yamada-Namikawa C, Ogawa S, Mase S, Goto S, Nishikawa R,
Inagaki H, Kato Y, Sugiura-Ogasawara M.Oncol
Lett. 2022 May 17;24(1):214. doi: 10.3892/ol.2022.13334. eCollection 2022 Jul.PMID: 35720483 Free PMC
article.
Clinical impact of
the pathological quantification of myocardial fibrosis and infiltrating T
lymphocytes using an endomyocardial biopsy in patients with hypertrophic
cardiomyopathy. Shintani
Y, Nakayama T, Masaki A, Yokoi M, Wakami K, Ito T, Goto T, Sugiura T, Inagaki
H, Seo Y.Int
J Cardiol. 2022 Sep 1;362:110-117. doi: 10.1016/j.ijcard.2022.05.068. Epub 2022
May 31.PMID: 35662562
IRF4 drives clonal
evolution and lineage choice in a zebrafish model of T-cell lymphoma. Amanda
S, Tan TK, Ong JZL, Theardy MS, Wong RWJ, Huang XZ, Ali MZ, Li Y, Gong Z,
Inagaki H, Foo EY, Pang B, Tan SY, Iida S, Sanda T.Nat
Commun. 2022 May 3;13(1):2420. doi: 10.1038/s41467-022-30053-9.PMID: 35504924 Free PMC
article.
The implicated
clinical factors for outcomes in 304 patients with salivary duct carcinoma:
Multi-institutional retrospective analysis in Japan. Kusafuka
K, Sato Y, Nakatani E, Baba S, Maeda M, Yamanegi K, Ueda K, Inagaki H, Otsuki
Y, Kuroda N, Suzuki K, Iwai H, Imamura Y, Itakura J, Yamanaka S, Takahashi H,
Ito I, Akashi T, Daa T, Hamada M, Yasuda M, Kawata R, Yamamoto H, Tachibana Y,
Fukuoka J, Muramatsu A, Arai K, Suzuki M.Head
Neck. 2022 Jun;44(6):1430-1441. doi: 10.1002/hed.27034. Epub 2022 Mar 29.PMID: 35352425 Free PMC article.
Pleomorphic
adenoma: detection of PLAG1 rearrangement-positive tumor components using
whole-slide fluorescence in situ hybridization. Murase
T, Ishibashi K, Okumura Y, Ueda K, Nakano S, Fujii K, Masaki A, Nagao T, Inagaki
H.Hum
Pathol. 2022 Feb;120:26-34. doi: 10.1016/j.humpath.2021.11.010. Epub 2021 Dec
11.PMID: 34906590
Clinicopathological
significance of CD28 overexpression in adult T-cell leukemia/lymphoma. Sakamoto
Y, Ishida T, Masaki A, Takeshita M, Iwasaki H, Yonekura K, Tashiro Y, Ito A,
Kusumoto S, Iida S, Utsunomiya A, Ueda R, Inagaki H.Cancer
Sci. 2022 Jan;113(1):349-361. doi: 10.1111/cas.15191. Epub 2021 Nov 29.PMID: 34738707 Free PMC article.
The 2021 WHO
Classification of Tumors of the Thymus and Mediastinum: What Is New in Thymic
Epithelial, Germ Cell, and Mesenchymal Tumors? Marx
A, Chan JKC, Chalabreysse L, Dacic S, Detterbeck F, French CA, Hornick JL,
Inagaki H, Jain D, Lazar AJ, Marino M, Marom EM, Moreira AL, Nicholson AG,
Noguchi M, Nonaka D, Papotti MG, Porubsky S, Sholl LM, Tateyama H, Thomas de
Montpréville V, Travis WD, Rajan A, Roden AC, Ströbel P.J Thorac Oncol. 2022 Feb;17(2):200-213. doi: 10.1016/j.jtho.2021.10.010.
Epub 2021 Oct 22.PMID: 34695605 Review.
Salivary mucoepidermoid carcinoma: histological variants, grading systems,
CRTC1/3-MAML2 fusions, and clinicopathological features. Nakano
S, Okumura Y, Murase T, Nagao T, Kusafuka K, Urano M, Yamamoto H, Kano S,
Tsukahara K, Okami K, Kawakita D, Nagao T, Hanai N, Iwai H, Kawata R, Tada Y,
Nibu KI, Inagaki H.Histopathology.
2022 Mar;80(4):729-735. doi: 10.1111/his.14586. Epub 2021 Dec 14.PMID: 34657306
Frequency and impact on
clinical outcomes of sarcopenia in patients with idiopathic pulmonary fibrosis Kohei Fujita, Hirotsugu
Ohkubo, Akiko Nakano, Yuta Mori, Kensuke
Fukumitsu , Satoshi
Fukuda , Yoshihiro
Kanemitsu , Takehiro
Uemura , Tomoko Tajiri , Ken Maeno , Yutaka Ito 1 , Tetsuya Oguri , Yoshiyuki
Ozawa , Takayuki
Murase , Akio Niimi Chron Respir Dis. 2022
Jan-Dec;19PMID: 35930440 PMCID: PMC9358593 DOI: 10.1177/14799731221117298 Free PMC article
Long-term efficacy of
weekly paclitaxel therapy in unresectable primary squamous cell carcinoma of
the thyroid Sho Iwaki, Daisuke
Kawakita, Michi Sawabe, Takuma Matoba, Gaku Takano, Keisuke Oguri, Akihiro
Murashima, Kiyoshi
Minohara, Nobukazu
Tanaka, Hiroshi Tsuge, Sae Imaizumi, Ayano
Matsumura, Ayako Masaki, Takayuki
Murase, Masaki Ogawa, Shinichi
Iwasaki. Auris Nasus Larynx. 2022 Dec;49(6):1083-1087PMID: 34226099 DOI: 10.1016/j.anl.2021.06.005 case report
7-Amino-4-methylcoumarin
as a fluorescent substitute for Schiff's reagent: a new method that can be
combined with hemalum and eosin staining on the same tissue section Hiroshi
Takase, Takayuki
Murase, Daisuke
Hachisuka, Yuma
Sakamoto, Mariko
Sugiura , Satsuki
Nakano , Keiichiro
Fujii , Ayako
Masaki , Hiroshi
Inagaki Biotech Histochem. 2022
Jul 29;1-8. PMID: 35904399 DOI:10.1080/10520295.2022.2101144
Decreased peak expiratory flow rate associated with mortality in idiopathic
pulmonary fibrosis: A preliminary report Kohei
Fujita,Hirotsugu
Ohkubo, Akiko
Nakano, Norihisa
Takeda, Kensuke
Fukumitsu, Satoshi
Fukuda, Yoshihiro
Kanemitsu, Takehiro
Uemura, Tomoko
Tajiri, Ken
Maeno, Yutaka
Ito, Tetsuya
Oguri, Yoshiyuki
Ozawa, Takayuki
Murase, Akio Niimi Chron Respir Dis . 2022
Jan-Dec;19:14799731221114153. PMID: 35792724 PMCID: PMC9272050
DOI: 10.1177/14799731221114153
Free PMC article
IRF4 drives clonal evolution and lineage choice in a zebrafish model of
T-cell lymphoma Stella Amanda , Tze King Tan , Jolynn Zu Lin Ong , Madelaine Skolastika
Theardy , Regina Wan Ju Wong , Xiao Zi Huang , Muhammad Zulfaqar Ali , Yan
Li , Zhiyuan Gong , Hiroshi Inagaki , Ee Yong Foo , Brendan Pang , Soo Yong
Tan, Shinsuke Iida , Takaomi Sanda Nat Commun .
2022 May 3;13(1):2420. PMID: 35504924 PMCID: PMC9065160
DOI: 10.1038/s41467-022-30053-9 Free PMC article
Clinical impact
of the pathological quantification of myocardial fibrosis and infiltrating T
lymphocytes using an endomyocardial biopsy in patients with hypertrophic
cardiomyopathy Yasuhiro
Shintani , Takafumi Nakayama , Ayako Masaki , Masashi Yokoi , Kazuaki Wakami ,
Tsuyoshi Ito , Toshihiko Goto , Tomonori Sugiura , Hiroshi Inagaki , Yoshihiro Seo . Int J Cardiol . 2022 Sep
1;362:110-117. doi:
10.1016/j.ijcard.2022.05.068. Epub 2022 May 31.
Abnormal
accumulation of OFD1 in endometrial cancer with poor prognosis inhibits
ciliogenesis Ryuji Kojima, Esraa Hassan , Fumiko Ozawa , Chisato Yamada-Namikawa , Shino Ogawa , Shoko Mase , Shinobu Goto , Ryutaro Nishikawa , Hiroshi Inagaki ,
Yoichi Kato , Mayumi Sugiura-Ogasawara Oncol Lett 2022
May 17;24(1):214. doi:
10.3892/ol.2022.13334. eCollection 2022 Jul. PMID: 35720483 PMCID: PMC9178698
DOI: 10.3892/ol.2022.13334
Serum
creatinine/cystatin C ratio is a surrogate marker for sarcopenia in patients
with idiopathic pulmonary fibrosis Kohei
Fujita , Hirotsugu Ohkubo , Akiko Nakano , Norihisa Takeda , Kensuke Fukumitsu
, Satoshi Fukuda , Yoshihiro Kanemitsu , Takehiro Uemura , Tomoko Tajiri , Ken Maeno , Yutaka Ito , Tetsuya Oguri ,
Yoshiyuki Ozawa , Takayuki Murase , Akio Niimi.BMC
Pulm Med 2022 May 23;22(1):203. PMID:
35606777 PMCID: PMC9128295 DOI: 10.1186/s12890-022-02000-3
The implicated clinical factors for outcomes in 304 patients with salivary
duct carcinoma: Multi-institutional retrospective analysis in Japan Kimihide
Kusafuka, Yoko Sato, Eiji Nakatani, Satoshi Baba, Matsuyoshi Maeda, Koji
Yamanegi, Kaori Ueda, Hiroshi Inagaki, Yoshiro Otsuki, Naoto Kuroda,Kensuke
Suzuki , Hiroshi Iw , Yoshiaki Imamura, Junya Itakura, Shoji Yamanaka, Hideaki
Takahashi, Ichiro Ito, Takumi Akashi, Tsutomu Daa, Mei Hamada, Masanori Yasuda,
Ryo Kawata, Hidetaka Yamamoto 19 , Yuri
Tachibana, Junya Fukuoka, Aya Muramatsu, Kazumori Arai, Makoto Suzuki.Head
Neck 2022 Jun;44(6):1430-1441 PMID: 35352425doi: 10.1002/hed.27034.
Thymic
Mucoepidermoid Carcinoma: A Clinicopathologic and Molecular Study. Murase T, Nakano S, Sakane T, Domen H, Chiyo M, Nagasaka S, Tanaka M, Kawahara
Y, Toishi M, Tanaka T, Nakamura S, Sawabata N, Okami J, Mukaida H, Tzankov
A, Szolkowska M, Porubsky S, Marx A, Roden AC, Inagaki H. Am J Surg Pathol.
2022 Mar 22. doi: 10.1097/PAS.0000000000001886.PMID:
35319525
The 2021 WHO Classification of Tumors of the Thymus and Mediastinum: What Is New in Thymic Epithelial, Germ Cell, and Mesenchymal Tumors?
Marx A, Chan JKC, Chalabreysse L, Dacic S, Detterbeck F, French CA, Hornick JL, Inagaki
H, Jain D, Lazar AJ, Marino M, Marom EM, Moreira AL, Nicholson AG, Noguchi
M, Nonaka D, Papotti MG, Porubsky S, Sholl LM, Tateyama H, Thomas de
Montpréville V, Travis WD, Rajan A, Roden AC, Ströbel P. J Thorac Oncol. 2022
Feb;17(2):200-213. doi: 10.1016/j.jtho.2021.10.010. Epub 2021 Oct 22. PMID:
34695605 Free article.
Clinicopathological
significance of CD28 overexpression in adult T-cell leukemia/lymphoma.
Sakamoto
Y, Ishida T, Masaki A, Takeshita M, Iwasaki H, Yonekura K, Tashiro Y, Ito A,
Kusumoto S, Iida S, Utsunomiya A, Ueda R, Inagaki H. Cancer Sci. 2022
Jan;113(1):349-361. doi: 10.1111/cas.15191. Epub 2021 Nov 29. PMID: 34738707
Free PMC article.
Abnormal
ciliogenesis in decidual stromal cells in recurrent miscarriage.
Hassan
E, Kojima R, Ozawa F, Yoshihara H, Goto S, Kitaori T, Inagaki H, Kato Y,
Sugiura-Ogasawara M. J Reprod Immunol. 2022 Mar;150:103486. doi:
10.1016/j.jri.2022.103486. Epub 2022 Jan 19. PMID: 35085989
Salivary
mucoepidermoid carcinoma: histological variants, grading systems, CRTC1/3-MAML2
fusions, and clinicopathological features.
Nakano
S, Okumura Y, Murase T, Nagao T, Kusafuka K, Urano M, Yamamoto H, Kano S,
Tsukahara K, Okami K, Kawakita D, Nagao T, Hanai N, Iwai H, Kawata R, Tada Y,
Nibu KI, Inagaki H. Histopathology. 2022 Mar;80(4):729-735. doi:
10.1111/his.14586. Epub 2021 Dec 14. PMID: 34657306
Pleomorphic
adenoma: detection of PLAG1 rearrangement-positive tumor components using
whole-slide fluorescence in situ hybridization.
Murase
T, Ishibashi K, Okumura Y, Ueda K, Nakano S, Fujii K, Masaki A, Nagao T, Inagaki
H. Hum Pathol. 2022 Feb;120:26-34. doi: 10.1016/j.humpath.2021.11.010. Epub
2021 Dec 11. PMID: 34906590
村瀬貴幸、稲垣宏
結果の読み方がよくわかる!耳鼻咽喉科検査ガイドVI 頭頚部腫瘍の検査 免疫染色
耳鼻咽喉科・頭頚部外科 94巻204-212 2022 総説
2021年
Newly diagnosed follicular
lymphoma during pembrolizumab treatment for lung cancer. Marumo Y, Kusumoto S, Masaki A,
Nakashima T, Kikuchi T, Mori F, Komatsu H, Inagaki H, Iida S, Inagaki A. Int J
Hematol. 2021 Mar 27. doi: 10.1007/s12185-021-03135-5. Online ahead of print.
PMID: 33772730
Salivary Duct Carcinoma With
Rhabdoid Features-No or Aberrant Expression of E-cadherin and Genetic Changes
in CDH1: Immunohistochemical and Genetic Analyses of 17 Cases. Kusafuka K, Yamada H, Ishino K,
Maeda M, Yamanegi K, Baba S, Ohuchi T, Inagaki H, Yamamoto H, Iwasaki T,
Tsuchiya C, Sugimura H, Suzuki M. Am J Surg Pathol. 2021 Apr 1;45(4):439-449.
doi: 10.1097/PAS.0000000000001672. PMID: 33538422
Pathological evaluation of tumor
grade for salivary adenoid cystic carcinoma: A proposal of an objective grading
system. Morita N, Murase T, Ueda K, Nagao
T, Kusafuka K, Nakaguro M, Urano M, Taguchi K, Yamamoto H, Kano S, Tada Y,
Tsukahara K, Okami K, Onitsuka T, Fujimoto Y, Kawakita D, Sakurai K, Nagao T,
Hanai N, Kawata R, Hato N, Otsuki N, Nibu K, Inagaki H. Cancer Sci. 2021
Mar;112(3):1184-1195. doi: 10.1111/cas.14790. Epub 2021 Feb 2. PMID: 33377247
Mutation Profile of Thymic
Carcinoma and Thymic Neuroendocrine Tumor by Targeted Next-generation
Sequencing. Sakane T*, Sakamoto Y, Masaki A,
Murase T, Okuda K, Nakanishi R, Inagaki H*. Clin Lung Cancer. 2021
Mar;22(2):92-99. PMID: 33414055
Clinical significance of CD28
gene-related activating alterations in adult T-cell leukemia/lymphoma. Sakamoto Y*, Ishida T*, Masaki A,
Takeshita M, Iwasaki H, Yonekura K, Tashiro Y, Ito A, Kusumoto S, Utsunomiya A,
Iida S, Ueda R, Inagaki H*. Br J Haematol. 2021 Jan;192(2):281-291. doi:
10.1111/bjh.17211. Epub 2020 Nov 18. PMID:33205842
Prion diseases reported in the
"Annual of the Pathological Autopsy Cases in Japan". Horimoto Y, Sato C, Inagaki A,
Tajima T, Hibino H, Kabasawa H, Inagaki H. J Neurol Sci. 2021 Jan
15;420:117215. doi: 10.1016/j.jns.2020.117215. Epub 2020 Nov 2. PMID: 33183777
The Myoepithelial Cells of
Salivary Intercalated Duct-type Intraductal Carcinoma Are Neoplastic: A Study
Using Combined Whole-slide Imaging, Immunofluorescence, and RET Fluorescence In
Situ Hybridization. Bishop JA, Rooper LM, Sangoi AR,
Gagan J, Thompson LDR, Inagaki H. Am J Surg Pathol. 2021 Apr 1;45(4):507-515.
doi: 10.1097/PAS.0000000000001605.
Immunohistochemistry for CCR4
C-terminus predicts CCR4 mutations and mogamulizumab efficacy in adult T-cell
leukemia/lymphoma. Fujii
K*, Sakamoto Y*, Masaki A, Murase T, Tashiro Y, Yonekura K, Utsunomiya A, Ito
A, Kusumoto S, Iida S, Ueda R, Ishida T*, Inagaki H*. J Pathol Clin Res. 2021
Jan;7(1):52-60. doi: 10.1002/cjp2.180. Epub 2020 Oct 6. PMID:33022137
WHO
classification, thoracic tumors, in press (2021)
1.7.0.2 MALT
lymphoma of the lung Cooper Wendy
A. Cook James Inagaki
HiroshiCooper Wendy
A. Chan John K.C.
5.1.4.4
Mucoepidermoid carcinoma of the thymus Chan John K.C. Inagaki
Hiroshi Roden Anja C. Chan John K.C. Marx Alexander
7.0.0.3 MALT
lymphoma of the mediastinum Inagaki
Hiroshi Cook James Cooper Wendy
A. Marx Alexander Chan John K.C.
特集 カラーアトラス 基本から学ぶ病理組織の見方 病理診断の基本の「き」 日常診療に必要な分子病理診断 稲垣宏 耳鼻咽喉科・頭頸部外科 2021;93:210-215
2020年
"Pure" large cell
neuroendocrine carcinoma of the biliary tract associated with neurofibromatosis
type 1. Shuying Jiang, Yukio Fujiyoshi,
Ren Yagami. Pathol Int. 2020 Sep;70(9):692-694.doi: 10.1111/pin.12979. Epub
2020 Jul 2. PMID: 32614111
Next-generation sequencing assay
in salivary gland cytology: A pilot study. Yamamoto S*, Sakamoto Y*, Nakano
S, Fujii K, Ueda K, Okumura Y, Tsuda K, Masaki A, Kawakita D, Murase T, Inagaki
H*. J Oral Pathol Med. 2020 Nov;49(10):1037-1043. doi: 10.1111/jop.13109. Epub
2020 Sep 30. PMID: 32941702
Clinical significance of
tryptophan catabolism in follicular lymphoma. Masaki A, Ishida T, Maeda Y, Ito
A, Suzuki S, Narita T, Kinoshita S, Yoshida T, Ri M, Kusumoto S, Komatsu H,
Inagaki H, Ueda R, Choi I, Suehiro Y, Iida S. Hematol Oncol. 2020 Dec;38(5):742-753. PMID: 32940915
Prognostic impact of
CRTC1/3-MAML2 fusions in salivary gland mucoepidermoid carcinoma: A
multiinstitutional retrospective study. Okumura Y*, Nakano S*, Murase T,
Ueda K, Kawakita D, Nagao T, Kusafuka K, Urano M, Yamamoto H, Kano S, Tsukahara
K, Okami K, Nagao T, Hanai N, Iwai H, Kawata R, Tada Y, Nibu KI, Inagaki H*.
Cancer Sci. 2020. Nov;111(11):4195-4204. PMID:
32860299
The impact of clinicopathological
factors on clinical outcomes in patients with salivary gland adenoid cystic
carcinoma: a multi-institutional analysis in Japan. Kawakita D, Murase T, Ueda K,
Kano S, Tada Y, Tsukahara K, Okami K, Onitsuka T, Fujimoto Y, Matoba T, Sakurai
K, Nagao T, Hanai N, Kawata R, Hato N, Nibu KI, Urano M, Taguchi KI, Nakaguro
M, Kusafuka K, Yamamoto H, Nagao T, Inagaki H. Int J Clin Oncol. 2020
Oct;25(10):1774-1785. PMID: 32613404
Central pathology review of
salivary gland adenoid cystic carcinoma.Ueda K, Murase T, Nagao T,
Kusafuka K, Urano M, Yamamoto H, Nakaguro M, Taguchi KI, Masaki A, Hirai H,
Kawakita D, Tsukahara K, Hato N, Nagao T, Fujimoto Y, Sakurai K, Hanai N, Kano
S, Onitsuka T, Okami K, Nibu KI, Tada Y, Kawata R, Inagaki H. Head Neck. 2020
Aug;42(8):1721-1727. doi: 10.1002/hed.26081. Epub 2020 Jan 23. PMID: 31970840
Clinicopathological significance
of EGFR pathway gene mutations and CRTC1/3-MAML2 fusions in salivary gland
mucoepidermoid carcinoma.Morita M, Murase T, Okumura Y,
Ueda K, Sakamoto Y, Masaki A, Kawakita D, Tada Y, Nibu KI, Shibuya Y, Inagaki
H. Histopathology. 2020 Jun;76(7):1013-1022. PMID: 32129900
Mixed-type primary germ cell
tumor of the mediastinum in a young adult male with a sudden life threatening
condition: A case report.Sakane T, Okuda K, Murase T,
Watanabe T, Oda R, Tatematsu T, Yokota K, Haneda H, Inagaki H, Nakanishi R.
Thorac Cancer. 2020 Jan;11(1):166-169. doi: 10.1111/1759-7714.13231. Epub 2019
Nov 6. PMID: 31693305
Richter syndrome successfully
treated with ibrutinib monotherapy: two case reports.Fujinami H, Kusumoto S, Masaki A,
Ohshima Y, Tachita T, Sasaki H, Marumo Y, Yoshida T, Narita T, Ito A, Ri M,
Komatsu H, Inagaki H, Iida S.
Rinsho Ketsueki.
2019;60(10):1462-1467. doi: 10.11406/rinketsu.60.1462. PMID: 31695008
Autocrine
HGF/c-Met signaling pathway confers aggressiveness in lymph node adult T-cell
leukemia/lymphoma. Totani
H, Shinjo K, Suzuki M, Katsushima K, Mase S, Masaki A, Ito A, Ri M, Kusumoto S,
Komatsu H, Ishida T, Inagaki H, Iida S, Kondo Y. Oncogene. 2020
Aug;39(35):5782-5794. doi: 10.1038/s41388-020-01393-x. Epub 2020 Aug 4. PMID:
32747750
Nestin
Expression Affects Resistance to Chemotherapy and Clinical Outcome in Small
Cell Lung Cancer. Sone K, Maeno K, Masaki A,
Kunii E, Takakuwa O, Kagawa Y, Takeuchi A, Fukuda S, Uemura T, Fukumitsu K,
Kanemitsu Y, Ohkubo H, Takemura M, Ito Y, Oguri T, Inagaki H, Niimi A. Front
Oncol. 2020 Aug 6;10:1367. doi: 10.3389/fonc.2020.01367. eCollection 2020.
PMID: 32903755
Robust
CD8+ T-cell proliferation and diversification after mogamulizumab in patients
with adult T-cell leukemia-lymphoma. Saito
M, Ishii T, Urakawa I, Matsumoto A, Masaki A, Ito A, Kusumoto S, Suzuki S,
Takahashi T, Morita A, Inagaki H, Iida S, Ishida T. Blood Adv. 2020 May
26;4(10):2180-2191. doi: 10.1182/bloodadvances.2020001641. PMID: 32433748
A
novel pathophysiologic link between upper and lower airways in patients with
chronic rhinosinusitis: Association of sputum periostin levels with upper
airway inflammation and olfactory function.
Kanemitsu
Y, Suzuki M, Fukumitsu K, Asano T, Takeda N, Nakamura Y, Ozawa Y, Masaki A, Ono
J, Kurokawa R, Yap J, Nishiyama H, Fukuda S, Ohkubo H, Maeno K, Ito Y, Oguri T,
Izuhara K, Takemura M, Niimi A. World Allergy Organ J. 2020 Jan 6;13(1):100094.
doi: 10.1016/j.waojou.2019.100094. eCollection 2020 Jan. PMID: 32015784
Increased
Serum Periostin Levels and Eosinophils in Nasal Polyps Are Associated with the
Preventive Effect of Endoscopic Sinus Surgery for Asthma Exacerbations in
Chronic Rhinosinusitis Patients.
Kanemitsu Y, Kurokawa R, Ono J, Fukumitsu K, Takeda N, Fukuda S, Uemura
T, Tajiri T, Ohkubo H, Maeno K, Ito Y, Oguri T, Takemura M, Yap J, Nishiyama
H, Masaki A, Ozawa Y, Izuhara K, Suzuki M, Niimi A. Int Arch Allergy Immunol.
2020;181(11):862-870. doi: 10.1159/000509253. Epub 2020 Jul 30. PMID: 32731246
Pericardial
immunoglobulin G4-related inflammatory pseudotumor after right upper lobectomy
for lung cancer. Oda R, Okuda K, Murase T,
Sakane T, Tatematsu T, Yokota K, Endo K, Nakanishi R. Thorac Cancer. 2020
Oct;11(10):3034-3037. doi: 10.1111/1759-7714.13633. Epub 2020 Aug 26. PMID:
32844588
Basaloid
squamous cell carcinoma with adenoid cystic-like features of the head and neck
region: A report of two casesKimihide
Kusafuka 1 , Haruna Yagi 1 2 ,
Satoshi Baba 3 , Hiroshi Inagaki 4 , Chinatsu Tsuchiya 1 , Kazuki Hirata 1 , Aya Muramatsu 1 , Makoto Suzuki 1 , Kazumori Arai 1 , Tadashi Terada 1Pathol Int 2020
Oct;70(10):767-774.doi: 10.1111/pin.12986. Epub 2020 Jul 15. DOI:
10.1111/pin.12986 PMID: 32667090
特集 唾液腺腫瘍の診療最前線診断 病理診断 稲垣宏 耳鼻咽喉科・頭頸部外科 2020;92:696-702
2019年
Sakamoto Y, Fujii K, Murase S, Nakano S, Masaki A,
Murase T, Kusumoto S, Iida S, Utsunomiya A, Ueda R, Ishida T, Inagaki H. CCR4
is rarely expressed in CCR4-mutated T/NK-cell lymphomas other than adult T-cell
leukemia/lymphoma. Int J Hematol. 2019;110:389-392. PMID: 31468320
Ito A, Suzuki Y, Masaki A, Yoshida S, Suzushima H,
Takemoto S, Utsunomiya A, Ishii T, Hiura M, Takahashi T, Yurimoto S, Inagaki H,
Morita A, Iida S, Ishida T. PhD1Quantitatively immunological characterization
of mogamulizumab skin disorders in ATL patients. J Cutan Immunol Allergy. In
press.
Murase T, Ri M, Narita T, Fujii K, Masaki A, Iida S,
Inagaki H. Immunohistochemistry for identification of CCND1, NSD2, and MAF gene
rearrangements in plasma cell myeloma. Cancer Sci. 2019 Jun 20. doi:
10.1111/cas.14109. [Epub ahead of print] PubMed PMID: 31218784.
Sakane T, Murase T, Okuda K, Saida K, Masaki A, Yamada
T, Saito Y, Nakanishi R, Inagaki H. A mutation analysis of the EGFR pathway
genes, RAS, EGFR, PIK3CA, AKT1, and BRAF, and TP53 gene in thymic carcinoma and
thymoma type A/B3. Histopathology. 2019 Jun 10. doi: 10.1111/his.13936. [Epub
ahead of print] PubMed PMID: 31179560.
Murase T, Inagaki A, Masaki A, Fujii K, Narita T, Ri M, Hanamura I, Iida
S, Inagaki1 H. Plasma cell myeloma positive for t(14;20) with a relapse
in the central nervous system: A case report. J Clin Exp Hematol,2019 Sep 30;59(3):135-139.doi: 10.3960/jslrt.19011. PMID:31391406
Suzuki M, Ozaki S, Yokota M, Nakayama M, Murakami S,
Inagaki H, Nakamura Y, Hattori H. Sinonasal inverted papilloma associated with
small cell neuroendocrine carcinoma: a case report and literature review of
rare malignancies associated with inverted papilloma. Auris Nasus Larynx,
2019;46:641-650. PMID: 30545727
Suzuki Y, Saito M, Ishii T, Urakawa I, Matsumoto A,
Masaki A, Ito A, Kusumoto S, Suzuki S, Hiura M, Takahashi T, Morita A, Inagaki
H, Iida S, Ishida T. Mogamulizumab Treatment Elicits Autoantibodies Attacking
the Skin in Patients with Adult T-Cell Leukemia-Lymphoma. Clin Cancer Res. 2019
Jul 15;25(14):4388-4399. doi: 10.1158/1078-0432.CCR-18-2575. Epub 2019 Apr 24.
PubMed PMID: 31018922.
“WHO分類第4版による白血病・リンパ系腫瘍の病態学”
編者:木崎昌弘、田丸淳一 2019
13. 成熟B細胞性腫瘍
9)形質細胞腫瘍 稲垣宏、村瀬貴幸、李 政樹 pp254-280
10)節外性粘膜関連リンパ組織型辺縁帯リンパ腫 稲垣宏、村瀬貴幸 pp280-285
11)節性辺縁帯リンパ腫 稲垣宏、村瀬貴幸 pp285-287稲垣宏、村瀬貴幸、李政樹 形質細胞性腫瘍 pp254
坂本祐真、稲垣宏 成人T細胞性白血病/リンパ腫における抗CCR4抗体薬:CCR4遺伝子変異の意義 現代医学 2019;66:57-60.
2018年
Nakamura Y, Suzuki M, Ozaki S, Yokota M, Nakayama M, Hattori H, Inagaki
H, Murakami S. Sinonasal inverted papilloma associated with small cell neuroendocrine
carcinoma: A case report and literature review of rare malignancies associated
with inverted papilloma.
Auris Nasus Larynx. 2019 Aug;46(4):641-650. doi:
10.1016/j.anl.2018.10.009. Epub 2018 Dec 10.
Okumura
Y, Murase T, Saida K, Fujii K, Takino H, Masaki A, Ijichi K, Shimozato K, Tada
Y, Nibu KI, Inagaki H. Postoperative radiotherapy for T1/2N0M0 mucoepidermoid carcinoma positive for CRTC1/3-MAML2 fusions.Head Neck. 2018 Dec;40(12):2565-2573. doi: 10.1002/hed.24856. Epub 2018 Nov 26.PMID:
30475407
Sakane
T, Okuda K, Hattori H, Watanabe T, Oda R, Tatematsu T, Yokota K, Haneda H,
Inagaki H, Nakanishi R. Blastomatoid pulmonary carcinosarcoma: A rare case report and review of
the literature.
Thorac Cancer. 2018 Oct;9(10):1323-1326. doi: 10.1111/1759-7714.12831.
Epub 2018 Aug 14. Review.PMID:
30106243
Kinoshita
S, Ishida T, Ito A, Narita T, Masaki A, Suzuki S, Yoshida T, Ri M, Kusumoto S,
Komatsu H, Shimizu N, Inagaki H, Kuroda T, Scholz A, Ueda R, Sanda T, Iida S. Cyclin-dependent kinase 9 as a potential specific molecular target in
NK-cell leukemia/lymphoma.Haematologica. 2018 Dec;103(12):2059-2068. doi:
10.3324/haematol.2018.191395. Epub 2018 Aug 3.PMID:
30076184
Sakamoto Y, Ishida T, Masaki A, Murase T, Yonekura K, Tashiro Y, Tokunaga
M, Utsunomiya A, Ito A, Kusumoto S, Iida S, Ueda R, Inagaki H. CCR4 mutations
associated with superior outcome of adult T-cell leukemia/lymphoma under
mogamulizumab treatment. Blood.
2018 Aug 16;132(7):758-761. doi: 10.1182/blood-2018-02-835991. Epub 2018 Jun
21. No abstract available. PMID:
29930010
Masaki
A, Ishida T, Suzuki S, Ito A, Narita T, Kinoshita S, Ri M, Kusumoto S, Komatsu
H, Inagaki H, Ueda R, Iida S. Human T-cell lymphotropic/leukemia virus type 1 (HTLV-1) Tax-specific
T-cell exhaustion in HTLV-1-infected individuals.Cancer Sci. 2018 Aug;109(8):2383-2390.
doi: 10.1111/cas.13654. Epub 2018 Jun 27.PMID:
29845702
Watanabe T, Okuda K, Murase T, Moriyama S, Haneda H, Kawano O, Yokota K,
Sakane T, Oda R, Inagaki H, Nakanishi R. Four immunohistochemical assays
to measure the PD-L1 expression in malignant pleural mesothelioma.Oncotarget.
2018 Apr 17;9(29):20769-20780. doi: 10.18632/oncotarget.25100. eCollection 2018
Apr 17.PMID:
29755688
Saida K, Murase T, Ito M, Fujii K, Takino H, Masaki A, Kawakita D, Ijichi K, Tada Y, Kusafuka K, Iida Y, Onitsuka T, Yatabe Y, Hanai N, Hasegawa Y, Shinomiya H, Nibu KI, Shimozato K, Inagaki H. Mutation
analysis of the EGFR pathway genes, EGFR, RAS, PIK3CA, BRAF, and AKT1, in
salivary gland adenoid cystic carcinoma. Oncotarget. 2018 Mar 30;9(24):17043-17055. doi: 10.18632/oncotarget.24818.
eCollection 2018 Mar 30.PMID:
29682203
Han S, Masaki A, Sakamoto Y, Takino H, Murase T, Iida S, Inagaki H. Improved clonality detection in Hodgkin lymphoma using a semi-nested modification of the BIOMED-2 PCR assay for IGH and IGK rearrangements: A paraffin-embedded tissue study.Pathol
Int. 2018 May;68(5):287-293. doi: 10.1111/pin.12660. Epub 2018 Mar 25.PMID:
29575591
Sakane
T, Murase T, Okuda K, Takino H, Masaki A, Oda R, Watanabe T, Kawano O, Haneda
H, Moriyama S, Saito Y, Yamada T, Nakanishi R, Inagaki H. A comparative study of PD-L1 immunohistochemical assays with four reliable
antibodies in thymic carcinoma.Oncotarget. 2018 Jan 8;9(6):6993-7009. doi:
10.18632/oncotarget.24075. eCollection 2018 Jan 23.PMID:
29467945
Miyake M, Ito Y, Suzuki H, Tomizawa M, Sato H, Liu M, Okamura A, Nakajima T, Ohtani K, Takino H, Inagaki H, Kamijima M. Epididymal phospholipidosis is a possible mechanism for spermatotoxicity
induced by the organophosphorus insecticide fenitrothion in ratsToxicol
Lett. 2018 Mar 15;285:27-33. doi: 10.1016/j.toxlet.2017.12.023. Epub 2017
Dec 30.PMID:
29292090
Aoyama
S, Masaki A, Sakamoto Y, Takino H, Murase T, Ohshima K, Yoshino T, Kato S,
Inagaki H.Achromobacter Infection Is Rare in Japanese Patients with Pulmonary B-cell
Lymphoma.Intern Med. 2018 Mar 15;57(6):789-794. doi: 10.2169/internalmedicine.9430-17.
Epub 2017 Nov 20.PMID:
29151525
Masaki A, Ishida T, Maeda Y, Ito A, Suzuki S, Narita T, Kinoshita S, Takino
H, Yoshida T, Ri M, Kusumoto S, Komatsu H, Inagaki H, Ueda R, Choi I, Suehiro
Y, Iida S.Clinical significance of tryptophan catabolism in Hodgkin lymphoma.Cancer
Sci. 2018 Jan;109(1):74-83. doi: 10.1111/cas.13432. Epub 2017 Nov 29.
稲垣宏 唾液腺腫瘍にみられる遺伝子異常 特集 頭頸部腫瘍I 唾液腺腫瘍 病理と臨床 2018;36 (3):242-248
稲垣宏 低悪性度B細胞りンパ腫、マントル細胞リンパ腫、第2章 各論 A.病理診断入門 セミナー8リンパ腫セミナー:基本から学べるWHO分類改訂第4版(2017)52-63 南江堂 東京 2018
稲垣宏、吉野正 粘膜関連リンパ組織型節外性辺縁帯リンパ腫(MALTリンパ腫)、各論2 成熟B細胞腫瘍114-119 中村栄男、大島孝一、竹内賢吾、田丸淳一、中村直哉、吉野正 編 文光堂 東京2018
稲垣宏 16.マントル細胞リンパ腫、第2章 成熟B細胞腫瘍 WHO血液腫瘍分類:WHO分類2017をうまくかつようするために 改訂版 直江知樹、小松則夫、宮崎泰司、中村栄男、飯田真介、大島孝一、木下朝博、吉野正 編 p258-262 医薬ジャーナル 大阪、東京 2018
2017年
Miyake M, Ito Y,
Suzuki H, Tomizawa M, Sato H, Liu M, Okamura A, Nakajima T,Ohtani K, Takino
H, Inagaki H, Kamijima M. Epididymal phospholipidosis is apossible mechanism
for spermatotoxicity induced by the organophosphorusinsecticide
fenitrothion in rats. Toxicol Lett. 2018 Mar 15;285:27-33. doi:10.1016/j.toxlet.2017.12.023.
Epub 2017 Dec 30. PubMed PMID: 29292090.
Aoyama S, Masaki
A, Sakamoto Y, Takino H, Murase T, Ohshima K, Yoshino T, Kato S, Inagaki H.
Achromobacter Infection Is Rare in Japanese Patients with Pulmonary B-cell Lymphoma.
Intern Med. 2018 Mar 15;57(6):789-794. doi:10.2169/internalmedicine.9430-17.
Epub 2017 Nov 20. PubMed PMID: 29151525; PubMed Central PMCID:
PMC5891515.
Masaki A, Ishida
T, Maeda Y, Ito A, Suzuki S, Narita T, Kinoshita S, Takino H, Yoshida T, Ri M,
Kusumoto S, Komatsu H, Inagaki H, Ueda R, Choi I, Suehiro Y, Iida S. Clinical significance
of tryptophan catabolism in Hodgkin lymphoma. Cancer Sci. 2018
Jan;109(1):74-83. doi: 10.1111/cas.13432. Epub 2017 Nov 29. PubMed PMID: 29080383; PubMed Central PMCID: PMC5765298.
Narita T, Ishida T, Ito A, Masaki A, Kinoshita S, Suzuki S, Takino H, Yoshida
T, Ri M, Kusumoto S, Komatsu H, Imada K, Tanaka Y, Takaori-Kondo A, Inagaki
H, Scholz A, Lienau P, Kuroda T, Ueda R, Iida S.
Cyclin-dependent kinase 9 is a novel specific molecular target in adult
T-cell leukemia/lymphoma.
Blood. 2017 Aug 31;130(9):1114-1124.
doi: 10.1182/blood-2016-09-741983. Epub 2017 Jun 23. PubMed PMID: 28646117.
Sakamoto Y, Masaki A, Aoyama S, Han S, Saida K, Fujii K, Takino H, Murase T, Iida S, Inagaki H.
Improved clonality detection in B-cell lymphoma using a semi-nested modification
of the BIOMED-2 PCR assay for IGH rearrangement: A paraffin-embedded tissue
study.
Pathol Int. 2017 Sep;67(9):453-460.
doi: 10.1111/pin.12566. PubMed PMID: 28868745.
Fujii K, Murase T, Beppu S, Saida K, Takino H, Masaki A, Ijichi K, Kusafuka
K, Iida Y, Onitsuka T, Yatabe Y, Hanai N, Hasegawa Y, Inagaki H.
MYB, MYBL1, MYBL2 and NFIB gene alterations and MYC overexpression in salivary
gland adenoid cystic carcinoma.
Histopathology. 2017 Jun 8.
doi: 10.1111/his.13281. [Epub ahead of print] PubMed PMID: 28594149.
Ito Y, Fujii K, Murase T, Saida K, Okumura Y, Takino H, Masaki A, Beppu
S, Kawakita D, Ijichi K, Inagaki H.
Striated duct adenoma presenting with intra-tumoral hematoma and papillary thyroid carcinoma-like histology.
Pathol Int. 2017 Jun;67(6):316-321.
doi: 10.1111/pin.12534. Epub 2017 Apr 25. PubMed PMID: 28440555.
Beppu S, Ito Y, Fujii K, Saida K, Takino H, Masaki A, Murase T, Kusafuka
K, Iida Y, Onitsuka T, Yatabe Y, Hanai N, Hasegawa Y, Ijichi K, Murakami
S, Inagaki H.
Expression of cancer/testis antigens in salivary gland carcinomas with reference to MAGE-A and NY-ESO-1 expression in adenoid cystic carcinoma.
Histopathology. 2017 Aug;71(2):305-315.
doi: 10.1111/his.13226. Epub 2017 Jun 2. PubMed PMID: 28370175.
Kusafuka K, Kawasaki T, Maeda M, Yamanegi K, Baba S, Ito Y, Inagaki H,
Nakajima T.
Salivary duct carcinoma with rhabdoid features: a salivary counterpart of pleomorphic lobular carcinoma of the breast.
Histopathology. 2017 Jan;70(2):164-173.
doi: 10.1111/his.12987. Epub 2016 Jun 8. PubMed PMID: 27079821.
Aoyama S, Masaki A, Sakamoto Y, Takino H, Murase T, Ohshima K, Yoshino T, Kato S, Inagaki H. Achromobacter infection is rare in Japanese patients with pulmonary B-cell lymphoma
Internal Medicine In press.
Okumura Y, Murase T, Saida K, Fujii K, Takino H, Masaki A, Ijichi K, Shimozato K, Tada Y, Nibu K, Inagaki H. Post-operative Radiotherapy for T1/2N0M0 Mucoepidermoid Carcinoma Positive for CRTC1/3-MAML2 Fusions. Head and Neck, in press.
Inagaki H, Bell D, Brandwein-Gensler M.
Mucoepidermoid carcinoma (Chapter 4).
WHO Classification of Head and Neck Tumours. 4th ed. Ed.
El-Naggar AK, Chan JKC, Grandis JR, Takara T, Slootweg PJ.
WHO Press Lyon 2017 pp127.
Brandwein-Gensler M Bell D, Inagaki H, Katabi N, Leibo I, Seethala R, Triantafyllou
A.
Mucoepidermoid carcinoma (Chapter 7).
WHO Classification of Head and Neck Tumours. 4th ed. Ed. El-Naggar AK, Chan JKC, Grandis JR, Takara T, Slootweg PJ. WHO Press Lyon 2017 pp163.
Wenig BM, Bell D, Chiosea S, Inagaki H, Seethala R.
Clear cell carcinoma (Chapter 4).
WHO Classification of Head and Neck Tumours. 4th ed. Ed.
El-Naggar AK, Chan JKC, Grandis JR, Takara T, Slootweg PJ.
WHO Press Lyon 2017 pp168.
Skalova A, Bell D, Bishop JA, Inagaki H, Seethala R, Vielh P. Secretory carcinoma (Chapter 4).
WHO Classification of Head and Neck Tumours. 4th ed. Ed.
El-Naggar AK, Chan JKC, Grandis JR, Takara T, Slootweg PJ.
WHO Press Lyon 2017 pp177.
稲垣宏、正木彩子
びまん性大細胞型B細胞リンパ腫および原発性縦隔大細胞型B細胞性リンパ腫の免疫表現型
特集/免疫表現型に基づいたリンパ系腫瘍の理解
血液内科 2017;74(6):765-770
稲垣宏 齋田昂佑. 腫瘍の検査:染色体・遺伝子転座―唾液腺がんを中心に.耳鼻咽喉科・頭頸部外科. 耳鼻咽喉科検査マニュアル 2017;89:291-299
2016年
Fujii K, Ishibashi K, Kato J, Kan J, Fujii K, Ito Y, Takino H, Masaki A, Murase T, Inagaki H.
Cellular Level Characterization of B-cells Infiltrating Pulmonary MALT Lymphoma Tissues
Virchows Archiv 2016;469:575-580. PMID:27600807
Kato J, Masaki A, Fujii K, Takino H, Murase T, Yonekura K, Utsunomiya A,
Ishida T, Iida S, Inagaki H.
Quantitative PCR for HTLV-1 Provirus in Adult T-cell Leukemia/Lymphoma Using Paraffin Tumor Sections Pathol Int 2016;66:618-621. PMID:27678343
Shinomiya H, Ito Y, Kubo M, Yonezawa K, Otsuki N, Iwae S, Inagaki H, Nibu
K.
Expression of Amphiregulin in Mucoepidermoid Carcinoma of the Major Salivary
Glands: A Molecular and Clinicopathological Study.
Hum Pathol 2016;57:37-44. PMID:27393417
Suzuki T, Kusumoto S, Yamashita T, Masuda A, Kinoshita S, Yoshida T, Takami-Mori
F, Takino H, Ito A, Ri M, Ishida T, Komatsu H, Ueda M, Ando Y, Inagaki
H, Iida S.
Labial salivary gland biopsy for diagnosing immunoglobulin light chain
amyloidosis: a retrospective analysis.
Ann Hematol. 2016 Jan;95(2):279-85. doi: 10.1007/s00277-015-2549-y. Epub
2015 Nov 10. PubMed PMID: 26555284.
稲垣宏:病理検査と病理診断の基礎.第2章 研修で学ぶべき診療・検査手技、B検査の基礎知識 整形外科研修ノート改訂第2版 (斎藤知行、大塚隆信、久保俊一編)診断と治療社、東京、 2016, 82-84
伊藤洋平、稲垣宏:唾液腺腫瘍 第2部 癌の分子病理学 B 臓器別 病理と臨床 臨時増刊号 癌の分子病理学 病理診断から治療標的探索まで (深山正久、金井弥栄、田中伸哉 編) 34;84-90:2016 文光堂 東京
飯島護丈:医薬品添加物の安全性(非臨床)に係る手引き ―規制情報並びにQ&A―
日本医薬品添加剤協会 安全性委員会2016
飯島護丈:医薬品に係わる添加物と剤型革新における安全性評価2016 日本毒性学会学術年会2016シンポジウム
2015年
Kominato S,
Kusumoto S, Masuda A, Ishida T, Komatsu H, Mizoshita T, Joh T, Niimi A, Inagaki
H, Iida S. [Case Report; An intestinal extranodal NK/T cell lymphoma mimicking
Crohn's disease]. Nihon Naika Gakkai Zasshi. 2015 Feb10;104(2):298-301. Japanese.
PubMed PMID: 26571710.
Inagaki H, Chan JKC, Jaffe ES, Harris NL, Moller P, Nakamura S. Thymic
extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue
(Chapter 3-6B). WHO Classification of Tumours. Pathology and Genetics of
Tumours of the Lung, Pleura, Thymus and Heart, 4th ed. Ed. Travis WD, Brambilla
E, Burke AP, Maex A, Nich
olson AG WHO Press Lyon 2015 pp270-271.
Narita T, Ri M, Masaki A, Mori F, Ito A, Kusumoto S, Ishida T, Komatsu
H, Iida S.
Lower expression of activating transcription factors 3 and 4 correlates
with shorter progression-free survival in multiple myeloma patients receiving
bortezomib plus dexamethasone therapy.
Blood Cancer J.2015 Dec 4;5:e373.
Masaki A, Ishida T, Maeda Y, Suzuki S, Ito A, Takino H, Totani H, Yoshida T, Kinoshita S, Ogura H, Narita T, Ri M, Kusumoto S, Inagaki A, Komatsu H, Niimi A, Ueda R, Utsunomiya A, Inagaki H, Iida S.
[Prognostic significance of tryptophan catabolism in adult T-cell leukemia/lymphoma].
Rinsho Ketsueki. 2015 Nov;56(11):2295-304.
doi: 10.11406/rinketsu.56.2295. Japanese. PubMed PMID: 26666715.
Kominato S, Kusumoto S, Masuda A, Ishida T, Komatsu H, Mizoshita T, Joh
T, Niimi A, Inagaki H, Iida S.
[Case Report; An intestinal extranodal NK/T cell lymphoma mimicking Crohn's
disease].
Nihon Naika Gakkai Zasshi. 2015 Feb 10;104(2):298-301. Japanese.
PubMed PMID: 26571710.
Ishibashi K, Ito Y, Masaki A, Fujii K, Beppu S, Sakakibara T, Takino H,
Takase H, Ijichi K, Shimozato K, Inagaki H.
Warthin-like Mucoepidermoid Carcinoma: A Combined Study of Fluorescence
In Situ Hybridization and Whole-slide Imaging.
Am J Surg Pathol. 2015 Nov;39(11):1479-87.
doi: 10.1097/PAS.0000000000000507. PubMed PMID: 26457352.
Masaki A, Ishida T, Maeda Y, Suzuki S, Ito A, Takino H, Ogura H, Totani H, Yoshida T, Kinoshita S, Narita T, Ri M, Kusumoto S, Inagaki A, Komatsu H, Niimi A, Ueda R, Utsunomiya A, Inagaki H, Iida S.
Prognostic Significance of Tryptophan Catabolism in Adult T-cell Leukemia/Lymphoma.
Clin Cancer Res. 2015 Jun 15;21(12):2830-9.
doi: 10.1158/1078-0432.CCR-14-2275. Epub 2015 Mar 18. PubMed PMID: 25788494.
Ito Y, Ishibashi K, Masaki A, Fujii K, Fujiyoshi Y, Hattori H, Kawakita
D, Matsumoto M, Miyabe S, Shimozato K, Nagao T, Inagaki H.
Mammary analogue secretory carcinoma of salivary glands: a clinicopathologic
and molecular study including 2 cases harboring ETV6-X fusion.
Am J Surg Pathol. 2015 May;39(5):602-10.
doi: 10.1097/PAS.0000000000000392. PubMed PMID: 25651470.
Totani H, Kusumoto S, Ishida T, Masuda A, Yoshida T, Ito A, Ri M, Komatsu
H, Murakami S, Mizokami M, Ueda R, Niimi A, Inagaki H, Tanaka Y, Iida S.
Reactivation of hepatitis B virus (HBV) infection in adult T-cell leukemia-lymphoma
patients with resolved HBV infection following systemic chemotherapy.
Int J Hematol. 2015 Apr;101(4):398-404.
doi: 10.1007/s12185-015-1750-z. Epub 2015 Jan 30. PubMed PMID: 25633779.
Takeuchi M, Kawai T, Suzuki T, Naiki T, Kawai N, Fujiyoshi Y, Inagaki H,
Kohri K, Hara M, Shibamoto Y.
MRI for differentiation of renal cell carcinoma with sarcomatoid component from other renal tumor types.
Abdom Imaging. 2015 Jan;40(1):112-9.
doi: 10.1007/s00261-014-0185-y. PubMed PMID: 24965897.
Inagaki H.
[Reactive lymphadenopathy and malignant lymphoma: a practical guide to differential diagnosis].
Rinsho Ketsueki.
2014 Oct;55(10):1989-98. Review. Japanese.
PubMed PMID: 25297764.
Suzuki T, Kusumoto S, Masaki A, Ishida T, Inagaki H, Iida S, Mori F.
CD30-positive primary bone marrow lymphoma mimicking Hodgkin lymphoma. Int J
Hematol. 2015 Feb;101(2):109-11.
doi: 10.1007/s12185-014-1714-8. Epub 2014 Nov 28. PubMed PMID: 25430086.
Prieto-Granada CN, Inagaki H, Mueller J.
Thymic Mucoepidermoid Carcinoma: Report of a Case With CTRC1/3-MALM2 Molecular Studies.
Int J Surg Pathol. 2015 Jun;23(4):277-83.
doi: 10.1177/1066896915576959. Epub 2015 Mar 17. PubMed PMID: 25782731.
稲垣宏、伊地知圭 第2部、組織型と診断の実際、I、悪性腫瘍(2)粘表皮癌 森永正二郎、高田隆、長尾俊孝 編 文光堂 2015 p23-31
稲垣宏、正木彩子: 4.病理診断のポイント. F. 反応性リンパ性病変とリンパ腫の鑑別のポイント 悪性リンパ腫治療マニュアル 改訂第4版 (飛内賢正、木下朝博、塚崎邦弘 編) 南江堂 東京 2015, 45-50
稲垣宏、正木彩子:肺リンパ腫・リンパ腫様肉芽腫症・膿胸関連リンパ腫 X 節外リンパ腫の臓器別特徴と治療 リンパ腫学 最近の研究動向 (谷脇雅史 編) 日本臨床 増刊号;73:638-644 日本臨床社 大阪 2015
稲垣宏,石橋 謙一郎 唾液腺癌における腫瘍特異的融合遺伝子:最近の進歩 ~ワルチン様粘表皮癌~ 日本唾液腺学会誌 2015;56:43-48
稲垣宏、坂本祐真 猫ひっかき病 特集/見逃されやすい頸部リンパ節腫脹の原因疾患 血液内科2015;71:376-379
正木彩子, 石田高司, 前田康弘, 鈴木進, 伊藤 旭, 滝野 寿, 戸谷治仁, 吉田嵩, 木下史緒理, 小椋 啓加, 成田朋子, 李政樹,
楠本茂, 稲垣淳, 小松弘和, 新実彰男, 上田 龍三, 宇都宮 與, 稲垣宏, 飯田真介 成人T細胞白血病/リンパ腫におけるトリプトファン代謝の予後に関する意義 臨床血液 2015;56:2295-2304
2014年
Design, synthesis, and biological activity of NCC149 derivatives as histone
deacetylase 8-selective inhibitors. Suzuki T, Muto N, Bando M, Itoh Y,
Masaki A, Ri M, Ota Y, Nakagawa H, Iida S, Shirahige K, Miyata N. ChemMedChem.
2014 Mar;9(3):657-64. doi: 10.1002/cmdc.201300414. Epub 2014 Jan 8. PMID:
24403121 [PubMed - indexed for MEDLINE] Similar articles
HTLV-1 bZIP factor-specific CD4 T cell responses in adult T cell leukemia/lymphoma
patients after allogeneic hematopoietic stem cell transplantation. Narita
T, Ishida T, Masaki A, Suzuki S, Ito A, Mori F, Yamada T, Ri M, Kusumoto
S, Komatsu H, Miyazaki Y, Takatsuka Y, Utsunomiya A, Niimi A, Iida S, Ueda
R. J Immunol. 2014 Feb 1;192(3):940-7. doi: 10.4049/jimmunol.1301952. Epub
2013 Dec 20. PMID: 24363428 [PubMed - indexed for MEDLINE] Free Article
Similar articles
Ge Y, Takino H,1 Sato F,1 Yamada S, Masaki A, Fujiyoshi Y, Hattori H, Morita
A, Kuo T-t, Inagaki H. Distinctive Immunoglobulin VH Gene Features of Cutaneous
Marginal Zone Lymphomas in Asian Cases
Br J Dermatol 2014;170:735-7
Miyabe K, Masaki A, Nakazawa T, Ando T, Hayashi K, Naitoh I, Okumura F, Shimizu S, Kondo H, Yoshida M, Yamashita H, Umemura S, Hori Y, Ge Y, Ohara H, Joh T, Inagaki H Histiocytic sarcoma of the bile duct Internal Medicine 2014;53:707-702
Mori F, Ishida T, Ito A, Sato F, Masaki A, Narita T, Suzuki S, Yamada T, Takino H, Ri M, Kusumoto S, Komatsu H, Hishizawa M, Imada K, Takaori-Kondo A, Niimi A, Ueda R, Inagaki H, Iida S Antitumor effects of bevacizumab in a microenvironment-dependent human adult T-cell leukemia/lymphoma mouse model
European Journal of Haematology 2014;92:219-28
Ogura M, Ishida T, Hatake K, Taniwaki M, Ando K, Tobinai K, Fujimoto K,
Yamamoto K, Miyamoto T, Uike N, Tanimoto M, Tsukasaki K, Ishizawa K, Suzumiya
J, Inagaki H, Tamura K, Akinaga S, Tomonaga M, Ueda R.
Multicenter phase II study of mogamulizumab (KW-0761), a defucosylated
anti-CCR4 antibody, in patients with relapsed peripheral T-cell lymphoma
and cutaneous T-cell lymphoma
J Clin Oncol 2014;32:1157-63
Xia H, Yamada S, Aoyama M, Sato F, Masaki A, Ge Y, Ri M, Ishida T, Ueda R, Utsunomiya A, Asai K, Inagaki H. Prognostic impact of miR-145 down-regulation in adult T-cell leukemia/ lymphoma
Human Pathology 2014;45(6):1192-8.
Narita T, Ishida T, Masaki A, Suzuki S, Ito A, Mori F, Yamada T, Ri M,
Kusumoto S, Komatsu H, Miyazaki Y, Takatsuka Y, Utsunomiya A, Niimi A,
Iida S, Ueda R.
HTLV-1 bZIP factor-specific CD4 T cell responses in adult T cell leukemia/lymphoma
patients after allogeneic hematopoietic stem cell transplantation. J Immunol.
2014 Feb 1;192(3):940-7.
Suzuki T, Muto N, Bando M, Itoh Y, Masaki A, Ri M, Ota Y, Nakagawa H, Iida
S, Shirahige K, Miyata N.
Design, synthesis, and biological activity of NCC149 derivatives as histone
deacetylase 8-selective inhibitors. ChemMedChem.
2014 Mar;9(3):657-64.
2013年
Ishida T, Ito A, Sato F, Kusumoto S, Iida S, Inagaki H, Morita A, Akinaga
S, Ueda R. Stevens-Johnson Syndrome associated with mogamulizumab treatment
of Adult T-cell leukemia/lymphoma
Cancer Sci 2013 May;104(5):647-50.
10.1111/cas.12116
Takino H, Li C, Yamada S, Sato F, Masaki A, Fujiyoshi Y, Hattori H, Inagaki H. Thymic Extranodal Marginal Zone Lymphoma of Mucosa-associated Lymphoid Tissue: A Gene Methylation Study Leuk Lymphoma 2013;54:1742-6
Kato H, Saito C, Ito E, Furuhashi T, Nishida E, Ishida T, Ueda R, Inagaki H, Morita A. Bath-PUVA therapy decreases infiltrating CCR4-expressing tumor cells and regulatory T cells in patients with mycosis fungoides
Clinical Lymphoma Myeloma and Leukemia, 2013 Jan 15. doi:pii: S2152-2650(12)00288-1.
Noda H, Okumura Y, Nakayama T, Miyabe S, Fujiyoshi Y, Hattori H, Shimozato K, Inagaki H. Clinicopathological Significance of MAML2 Gene Split in Mucoepidermoid Carcinoma Cancer Sci 2013;104:85-92
10.1111/cas.12039
Masaki A, Ishida T, Suzuki S, Ito A, Mori F, Sato F, Narita T, Yamada T, Ri M, Kusumoto S, Komatsu H, Tanaka Y, Niimi A, Inagaki H, Iida S, Ueda R
Autologous Tax-specific CTL therapy in a primary ATL cell-bearing
NOD/Shi-scid, IL-2Rγnull mouse model. J Immunol 2013;191:135-44
Suzuki S, Watanabe S, Kato H, Inagaki H, Hattori H, Morita A. A case of Scutaneous malignant fibrous histiocytoma with multiple organ metastases. Kaohsiung J Med Sci. 2013 Feb;29(2):111-5. doi: 10.1016/j.kjms.2012.08.019. Epub 2012 Oct 13. PubMed PMID: 23347814.
Shibata T, Matsuo Y, Shamoto T, Hirokawa T, Tsuboi K, Takahashi H, Ishiguro H, Kimura M, Takeyama H, Inagaki H.
Girdin, a regulator of cell motility, is a potential prognostic marker for esophageal squamous cell carcinoma. Oncol Rep. 2013 Jun;29(6):2127-32. doi: 10.3892/or.2013.2406. Epub 2013 Apr 12.
Takeuchi M, Urano M, Hara M, Fujiyoshi Y, Inagaki H, Shibamoto U. Characteristic MR Imaging Findings of Sarcomatoid Renal Cell Carcinoma Dedifferentiated from Clear Cell Renal Carcinoma: Radiological-Pathological Correlation Clinical Imaging 2013;37:908-912
Inagaki A, Tajima E, Uranishi M, Totani H, Asao Y, Ogura H, Masaki A, Yoshida T, Mori F, Ito A, Yano H, Ri M, Kayukawa S, Kataoka T, Kusumoto S, Ishida, T, Hayami Y, Hanamura I, Komatsu H, Inagaki H, Matsuda Y, Ueda R, Iida S
Global real-time quantitative reverse transcription-polymerase chain reaction detecting protooncogenes associated with 14q32 chromosomal translocation as a valuable marker for predicting survival in multiple myeloma. Leukemia Research 2013;37:1648-55
Sato F, Ishida T, Ito A, Mori F, Masaki A, Takino H, Narita T, Ri M, Kusumoto S, Suzuki S, Komatsu H, Niimi A, Ueda R, Inagaki H, Iida S. Angioimmunoblastic T-cell lymphoma mice model. Leuk Res. 2013 Jan;37(1):21-7. doi:pii: S0145-2126(12)00382-7.
2012年
Kobayashi S, Sakurai K, Tanikawa M, Nishikawa Y, Matsukawa N, Okita K, Fujiyoshi, Y, Shibamoto Y.
A case of central nervous system lymphoma manifesting as multiple patchy white matter lesions with a past history of tonsil lymphoma.
Kurume Medical Journal .2012;59:33-38
Fujiyoshi Y, Shuying J, Xia F
Intramucosal stomach adenocarcinoma metastasizing as a large intraabdominalmass with focal choriocarcinomatous differentiation.
Int J clin pathol.2012;5(8):845-851
Ebi M, Shimura T, Yamada S, Hirata Y, Tsukamoto H, Okamoto Y, Mizoshita T, Tanida S, Kataoka H, Kamiya T, Inagaki H, Joh T.
A patient with gastric adenosquamous carcinoma with intraperitoneal free cancer cells who remained recurrence-free with postoperative S-1 chemotherapy.
Internal Medicine .2012;51(22):3125-29
Sato F, Ishida T, Ito A, Mori F, Masaki A, Takino H, Narita T, Ri M, Kusumoto S,
Suzuki S, Komatsu H, Niimi A, Ueda R, Inagaki H, Iida S.
Angioimmunoblastic T-cell lymphoma mice model.
Leukemia research. 2012 Sep 28.
Suzuki S, Masaki A, Ishida T, Ito A, Mori F, Sato F, Narita T, Ri M, Kusumoto S,
Komatsu H, Fukumori Y, Nishikawa H, Tanaka Y, Niimi A, Inagaki H, Iida S, Ueda R.
Tax is a potential molecular target for immunotherapy of adult T-cell leukemia/lymphoma.
Cancer science. 2012 Oct;103(10):1764-73.
Yamada S, Sato F, Xia H, Takino H, Kominato S, Ri M, Ishida T,
Iida S, Inagaki H, Yamada K.
Forkhead box P1 overexpression and its clinicopathologic significance in peripheral T-cell lymphoma, not otherwise specified.
Hum Pathol. 2012 Aug;43(8):1322-7
Okumura F, Sakuma H, Nakazawa T, Hayashi K, Naitoh I, Miyabe K,
Yoshida M, Yamashita H, Ohara H, Inagaki H, Joh T.
Analysis of VH gene rearrangement and somatic hypermutation in type 1 autoimmune pancreatitis.
Pathol Int. 2012 May;62(5):318-23.
Wada N, Zaki MA, Kohara M, Ogawa H, Sugiyama H, Nomura S, Matsumura I,
Hino M, Kanakura Y, Inagaki H, Morii E, Aozasa K.
Diffuse large B cell lymphoma with an interfollicular pattern of proliferation shows a favourable prognosis: a study of the Osaka Lymphoma Study Group.
Histopathology. 2012 May;60(6):924-932
Ishida T, Joh T, Uike N, Yamamoto K, Utsunomiya A, Yoshida S, Saburi Y, Miyamoto T,
Takemoto S, Suzushima H, Tsukasaki K, Nosaka K, Fujiwara H, Ishitsuka K, Inagaki H,
Ogura M, Akinaga S, Tomonaga M, Tobinai K, Ueda R.
Defucosylated anti-CCR4 monoclonal antibody (KW-0761) for relapsed adult T-cell leukemia-lymphoma: a multicenter phase II study.
J Clin Oncol. 2012 Mar 10;30(8):837-42
Nishikawa H, Maeda Y, Ishida T, Gnjatic S, Sato E, Mori F, Sugiyama D, Ito A,
Fukumori Y, Utsunomiya A, Inagaki H, Old LJ, Ueda R, Sakaguchi S.
Cancer/testis antigens are novel targets of immunotherapy for adult T-cell leukemia/lymphoma.
Blood. 2012 Mar 29;119(13):3097-104
Kominato S, Nakayama T, Sato F, Yamada S, Xia H, Fujiyoshi Y, Hattori H, Inagaki H.
Characterization of chromosomal aberrations in thymic MALT lymphoma.
Pathol Int. 2012 Feb;62(2):93-8
Ri M, Tashiro E, Oikawa D, Shinjo S, Tokuda M, Yokouchi Y, Narita T, Masaki A, Ito A, Ding J, Kusumoto S, Ishida T, Komatsu H, Shiotsu Y, Ueda R, Iwawaki T, Imoto M, Iida S.
Identification of Toyocamycin, an agent cytotoxic for multiple myeloma
cells, as a potent inhibitor of ER stress-induced XBP1 mRNA splicing. Blood
Cancer J.
2012 Jul;2(7):e79. doi: 10.1038/bcj.2012.26. Epub 2012 Jul 20.
飯島 護丈:油脂・脂質・界面活性剤 データブック 日本油化学会編 丸善出版 2012 631-644
2011年
Ebi M, Kataoka H, Shimura T, Hirata Y, Mizushima T, Mizoshita T, Tanaka M, Tsukamoto H,
Ozeki K, Tanida S, Kamiya T, Inagaki H, Joh T.
The role of neuregulin4 and HER4 in gastrointestinal malignant lymphoma.
Mol Med Report. 2011 Nov-Dec;4(6):1151-5
Xia H, Nakayama T, Sakuma H, Yamada S, Sato F, Takino H, Okabe M,
Fujiyosi Y, Hattori H, Inagaki H
Analysis of API2-MALT1 fusion, trisomies, and immunoglobulin VH genes in pulmonary MALT lymphoma.
Human Pathol. 2011 Sep;42(9):1297-304
Okumura H, Miyabe S, Nakayama T, Fujiyoshi Y, Hattori H, Shimozato K,
Inagaki H
Impact of CRTC1/3-MAML2 Fusions on Histological Classification and Prognosis of Mucoepidermoid Carcinoma
Histopathology. 2011 Jul;59(1):90-7
Kojima M, Nakamura N, Nakazato Y, Igarashi T, Masawa N, Inagaki H.
Light-chain-restricted monocytoid B-cell cluster in reactive lymphadenitis associated with Sjögren syndrome.
Leuk Lymphoma. 2011 Jun;52(6):1150-2